These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


358 related items for PubMed ID: 20516805

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Levosimendan is not effective in reducing pulmonary pressures in patients with idiopathic pulmonary arterial hypertension: report of two cases.
    Cavusoglu Y, Beyaztas A, Birdane A, Ata N.
    J Cardiovasc Med (Hagerstown); 2009 Jun; 10(6):503-7. PubMed ID: 19346968
    [Abstract] [Full Text] [Related]

  • 3. Effects of levosimendan on right ventricular function in patients with advanced heart failure.
    Parissis JT, Paraskevaidis I, Bistola V, Farmakis D, Panou F, Kourea K, Nikolaou M, Filippatos G, Kremastinos D.
    Am J Cardiol; 2006 Dec 01; 98(11):1489-92. PubMed ID: 17126656
    [Abstract] [Full Text] [Related]

  • 4. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
    Follath F.
    Ital Heart J; 2003 May 01; 4 Suppl 2():34S-38S. PubMed ID: 14635368
    [Abstract] [Full Text] [Related]

  • 5. Levosimendan in two neonates with ischemic heart failure and pulmonary hypertension.
    De Carolis MP, Piastra M, Bersani I, Pardeo M, Stival E, Tempera A, Romagnoli C, Conti G, De Rosa G.
    Neonatology; 2012 May 01; 101(3):201-5. PubMed ID: 22067520
    [Abstract] [Full Text] [Related]

  • 6. Levosimendan: beyond its simple inotropic effect in heart failure.
    Antoniades C, Tousoulis D, Koumallos N, Marinou K, Stefanadis C.
    Pharmacol Ther; 2007 May 01; 114(2):184-97. PubMed ID: 17363065
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Can pulmonary artery hypertension be attributed to levosimendan? A problematic based on a patient's case.
    Tagarakis GI, Baddour AJ, Tsilimingas NB.
    J Cardiovasc Med (Hagerstown); 2010 Jul 01; 11(7):552-3. PubMed ID: 20035233
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of levosimendan in patients with acute right heart failure: A meta-analysis.
    Qiu J, Jia L, Hao Y, Huang S, Ma Y, Li X, Wang M, Mao Y.
    Life Sci; 2017 Sep 01; 184():30-36. PubMed ID: 28689804
    [Abstract] [Full Text] [Related]

  • 10. A promising new inotrope: levosimendan.
    Fotbolcu H, Duman D.
    Anadolu Kardiyol Derg; 2010 Apr 01; 10(2):176-82. PubMed ID: 20382619
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of levosimendan on acute pulmonary embolism-induced right ventricular failure.
    Kerbaul F, Gariboldi V, Giorgi R, Mekkaoui C, Guieu R, Fesler P, Gouin F, Brimioulle S, Collart F.
    Crit Care Med; 2007 Aug 01; 35(8):1948-54. PubMed ID: 17568324
    [Abstract] [Full Text] [Related]

  • 13. [Levosimendan for treatment of heart failure].
    Yasumura Y.
    Nihon Rinsho; 2007 May 28; 65 Suppl 5():169-72. PubMed ID: 17571380
    [No Abstract] [Full Text] [Related]

  • 14. Effects of levosimendan versus dobutamine on pressure load-induced right ventricular failure.
    Kerbaul F, Rondelet B, Demester JP, Fesler P, Huez S, Naeije R, Brimioulle S.
    Crit Care Med; 2006 Nov 28; 34(11):2814-9. PubMed ID: 16971854
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Levosimendan: implications for clinicians.
    McBride BF, White CM.
    J Clin Pharmacol; 2003 Oct 28; 43(10):1071-81. PubMed ID: 14517189
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Levosimendan.
    Kamath SR, Jaykumar I, Matha S.
    Indian Pediatr; 2009 Jul 28; 46(7):593-6. PubMed ID: 19638658
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.